Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with stroke
being among the most prevalent and harmful outcomes.
1
Because nearly 25% of patients with AF appear asymptomatic, questions regarding the
screening of patients at risk for AF (e.g., based on CHA2DS2-VASc score) could help clinical decisions to prescribe prophylactic anticoagulation
therapy for effective stroke prevention.
2
,3
Current evidence highlights new approaches of real-time continuous assessment of
rhythmic states of AF, non-AF, and paroxysmal AF (PAF).
4
- Chen LY
- Chung MK
- Allen LA
- Ezekowitz M
- Furie KL
- McCabe P
- Noseworthy PA
- Perez MV
- Turakhia MP
- Cardiology American Heart Association Council on Clinical
- Cardiovascular Council on
- Nursing Stroke
- Care Council on Quality of
- Research; Outcomes
- Council Stroke
Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity:
a scientific statement from the American Heart Association.
Circulation. 2018; 137: e623-e644
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Trends in atrial fibrillation-related cardiovascular mortality rates in the United States: 1999–2017.Circulation. 2020; 141 (A15–A15)
- Stroke as the first manifestation of atrial fibrillation.PLoS One. 2016; 11e0168010
- Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry.Chest. 2017; 152: 1266-1275
- Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association.Circulation. 2018; 137: e623-e644
- Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.Europace. 2016; 18: 1000-1005
- A review on wearable photoplethysmography sensors and their potential future applications in health care.Int J Biosens Bioelectron. 2018; 4: 195-202
- Cardiac arrhythmia detection using photoplethysmography.Annu Int Conf IEEE Eng Med Biol Soc. 2017; 2017: 113-116
- Utility of second derivative of the finger photoplethysmogram for the estimation of the risk of coronary heart disease in the general population.Circ J. 2006; 70: 304-310
- Cost-effectiveness of screening for atrial fibrillation using wearable devices.JAMA Health Forum. 2022; 3e222419
- Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement.JAMA. 2022; 327: 360-367
Article info
Publication history
Published online: December 09, 2022
Received in revised form:
October 31,
2022
Received:
August 20,
2022
Footnotes
Funding: none.
Identification
Copyright
© 2022 Published by Elsevier Inc.
